Neoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II/III TNBC Patients

Clinical trial NCT06353997 · RECRUITING

Trial details

NCT number: NCT06353997
Sponsor: Providence Health & Services
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Cancer

Start date: 2024-09-05
Primary completion: 2027-06-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.